CASI Pharmaceuticals's total assets for Q2 2025 were $31.20M, a decrease of -23.56% from the previous quarter. CASI total liabilities were $51.51M for the fiscal quarter, a 5.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.